Argeris N. Karabelas, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 133,576 shares at $11.30 ($1.5M) on 2009-12-08, disclosed to the SEC on 2009-12-10.
Open-market sale of $1.5M VNDA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.30 | 26,376 | $298K | 19.4% |
| 2 | $11.57 | 107,200 | $1.2M | 80.6% |
| Total | $11.52 avg | 133,576 | $1.5M | 100% |
| Filing → |
| RGNX | SELL | 2024-08-05 | $136K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $166K | — | Filing → |
| RGNX | SELL | 2024-07-03 | $113K | — | Filing → |